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A randomized controlled trial to assess the central
hemodynamic response to exercise in patients with transient
ischaemic attack and minor stroke
J Faulkner1, Y-C Tzeng2,3, D Lambrick4, B Woolley5, PD Allan2,3, T O’Donnell2, J Lanford6, L Wong6 and L Stoner7
Early exercise engagement elicits meaningful changes in peripheral blood pressure in patients diagnosed with transient ischaemic
attack (TIA) or minor stroke. However, central hemodynamic markers may provide clinicians with important diagnostic and
prognostic information beyond that provided by peripheral blood pressure readings. The purpose of this single-centre, randomized,
parallel-group clinical trial was to determine the effect of a 12-week aerobic exercise intervention on central and peripheral
hemodynamic variables in patients with TIA or minor stroke. In this study, 47 participants (66 ± 10 years) completed a baseline
assessment, which involved the measurement of central and peripheral hemodynamic parameters, undertaken in the morning, in a
fasted state. Participants were randomized to either a 12-week exercise or control group on completion of the baseline assessment.
An identical follow-up assessment was completed post intervention. Central hemodynamic variables were assessed using an
oscillometric device at both assessments. Analysis of covariance demonstrated a signiﬁcant interaction for central and peripheral
blood pressure and augmentation index (all Po0.05; ηp2.09–.11), with the exercise group presenting lower values than the control
group post intervention (118 ± 17 vs 132 ± 28 mm Hg for central blood pressure; 125 ± 19 vs 138 ± 28 mm Hg for peripheral blood
pressure; 104 ± 49 vs 115 ± 67% for augmentation index). The present study demonstrates that participation in an exercise program
soon after stroke/TIA diagnosis may elicit signiﬁcant beneﬁcial changes to a patient’s central systolic blood pressure and
augmentation index. This may positively impact upon the treatment strategies implemented by clinicians in the care of patients
with TIA and minor stroke.
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INTRODUCTION
Blood pressure is an important risk factor for stroke,1 and is
widely cited as a marker that needs to be controlled post stroke
by pharmacological and lifestyle management.2 A recent meta-
analysis with stroke and transient ischaemic attack (TIA) patients
has shown that signiﬁcant reductions in peripheral blood pressure
responses may be evident following participation in behavioural
interventions (that is, exercise, lifestyle management programs).3
However, the measurement of central hemodynamic parameters,
including central systolic blood pressure (cSBP) and arterial wave
reﬂection (that is, augmentation index, AIx), hold the potential to
provide stroke clinicians with important diagnostic and prognostic
information beyond that of peripheral blood pressure readings.
Peripheral blood pressures may not accurately reﬂect the effects
of peak arterial blood pressure on centrally located organs such as
the heart and brain.4 This is important because individuals who
experience a stroke or TIA are at heightened risk of experiencing
subsequent vascular events, whether from a cerebrovascular (that
is, stroke/TIA) or cardiovascular (that is, myocardial infarction)
origin.5,6 Thus, the assessment of cSBP is particularly important as
it reﬂects the stress and loading on the left ventricle and coronary
arteries.7,8 Yet to date, the effects of secondary prevention
behavioural interventions on central blood pressure responses in
stroke or TIA patients have not been assessed. As behavioural
interventions which have incorporated exercise training,
counseling and lifestyle education reduce the risk of subsequent
cardiac events in patients with stroke,3 further research is
necessary to elucidate the underlying central hemodynamic
response to these types of intervention for patients with stroke
or TIA.
The purpose of the current randomized control study was to
determine the effect of implementing an exercise program
soon after minor stroke/TIA diagnosis on cSBP and AIx. It
was hypothesised that those individuals who engaged in the
exercise program would demonstrate greater changes in central
hemodynamic responses compared with those individuals
randomized to a usual care control group.
METHODS
Participants
Forty-seven participants (Male, n=35; 66 ± 10 years; 90 ± 19 kg; 173 ± 7 cm;
Female, n= 12; 64 ± 12 years; 80 ± 20 kg; 159 ± 4 cm) diagnosed with either
TIA or minor stroke completed the baseline assessment, of which 43 took
part part in a post-intervention assessment (Figure 1). Recruitment
commenced in September 2013 and lasted 12 months with participants
being randomized to either an exercise or usual care control group
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(exercise group, n= 25; 66 ± 12 years; 88 ± 19 kg; 168 ± 10 cm; control
group, n= 22; 68 ± 10 years; 90 ± 21 kg; 171 ± 8 cm). Follow-up
(post-intervention) assessments were completed between December
2013 and December 2014.
TIA and minor stroke diagnosis was based upon criteria from the New
Zealand assessment and management guidelines.9 At the time of hospital
presentation within the inpatient setting, stroke severity was assessed
using the National Institutes of Health Stroke Scale, functional severity was
assessed using the Barthel Index, and stroke risk of TIA patients was
assessed using the ABCD2 score. Participants were eligible if they had been
diagnosed with their ﬁrst high-risk TIA (ABCD2 score of ⩾ 2) or minor stroke
(deﬁned as an National Institutes of Health Stroke Scale of ⩽ 5), lived within
the local district health board catchment, and if they did not meet
exclusion criteria (Figure 1). Exclusion criteria were: unstable cardiac
conditions, uncontrolled diabetes mellitus, severe claudication, oxygen
dependence, signiﬁcant dementia, inability to communicate in English or
unable to take part in exercise. All participants complied with drug
treatment and standardised therapy in accordance with stroke physician
recommendations. The trial was approved by New Zealand’s Central
Regional Health and Disabilities Ethics Committee and registered with the
Australian and New Zealand Clinical Trials Registry (Trial Registration
Number: ACTRN12613000869774), and conformed to the guidelines
established in the Declaration of Helsinki. Written informed consent was
obtained before participation.
Sample size
On the basis of the ﬁndings of Woolley et al.,10 and when examining
changes in peripheral systolic blood pressure (pSBP) in TIA patients
following participation in an exercise intervention, and when using a
two-sided 5% signiﬁcance level and a power of 80%, a minimum sample
size of 19 participants per group was calculated.
Study design
The study was a single-centre, randomized, parallel-group design. TIA or
minor stroke was conﬁrmed by a specialist stroke physician at Wellington
Hospital within 7 days of symptom onset. Eligible participants were invited
to attend a baseline assessment conducted within a thermoneutral
laboratory (21–22 °C) typically between 0700 and 1000 hours All
participants were fasted (overnight fast), euhydrated, had abstained from
caffeine and supplement intake during the morning, and from strenuous
physical activity and alcohol consumption for 24 h before assessment.
Following completion of a health history questionnaire, and 15 min of
quiet supine rest, central blood pressure responses were obtained with the
participant in the supine position. Identical assessments were completed
post-intervention.
On completion of the baseline assessment, participants were
randomized to either an experimental group (usual care plus participation
in a 12-week aerobic exercise intervention) or to a control group (usual
care, only) using computerized random numbers. Details pertaining to
each allocated group were provided on a piece of paper contained within
sequentially numbered, opaque sealed envelopes. The randomization
procedures were prepared by an investigator with no clinical involvement
in the trial. Although participants and the health and exercise practitioner
were aware of the allocated treatment condition, data analysts were kept
blinded to the allocation.
Subjects randomized to the exercise program completed twice weekly,
group-based (three to ﬁve participants) exercise sessions for 12 weeks.
Exercise was prescribed on a one-to-one basis by health and exercise
practitioners. In accordance with recommendations for moderate physical
activity participation, participants completed 30–60 min of aerobic exercise
at each exercise session.11 This included up to 30 min of continuous
walking and up to 30 mins of continuous cycling, with an interim period of
~ 5 min of passive recovery between bouts. Blood pressure, heart rate and
ratings of perceived exertion were measured prior to, during and following
each bout of aerobic exercise. Participants commenced their exercise
Figure 1. Participant recruitment.
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program at 50% of age-predicted maximal heart rate during all aerobic
exercise tasks. The exercise intensity and/or volume typically increased by
~ 5% each week, up to a maximal heart rate training intensity of 90% of
age-predicted maximal heart rate. The rate of progression was dependent
upon how the subject felt during each session. Subjects were
instructed not to exercise beyond an ratings of perceived exertion of 15
(‘hard’ feeling of exertion) during both walking and cycling exercise.12
Exercise practitioners ensured that subjects did not exercise above 90% of
their age-predicted maximal heart rate.
The control group (usual care) received standard secondary prevention
and educational information from the hospital on discharge and
were requested to adhere to their prescribed medication for the duration
of the study.
Pulse wave analysis
An oscillometric device (BP+, Uscom Lts, Sydney, NSW, Australia) was used
to conduct pulse wave analysis, from which central and peripheral blood
pressures and AIx were derived. The AIx% is an independent predictor of
cardiovascular risk and mortality.13 Pressure waveforms were recorded on
the upper arm, following standard manufacturer guidelines.14 Brieﬂy, the
BP+ incorporates an oscillometric blood pressure module which complies
with the Association for the Advancement of Medical Instrumentation
(AAMI SP10) requirements and receives an A/A rating from the British
Hypertension Society evaluation protocol.15 Each measurement cycle
(~40 s) records brachial blood pressures and then one set of suprasystolic
(~30 mm Hg4systolic) recordings for 10 s. The suprasystolic pressure
signals were recorded by a high-ﬁdelity pressure transducer, and the
central pressure waveform was derived in the time-domain from
the relationship between the total oscillatory pressure in the aorta and
the total oscillatory pressure under the occlusion cuff.15,16 This estimation
was scaling-independent (that is, the estimated aortic wave shape did
not depend on brachial blood pressure). AIx% was calculated using the
formula: AIx%= (P3 – P0)/(P1 – P0), where P0 is pressure at the onset of the
pulse (diastolic), P1 is peak pressure of the incident wave (systolic),
P3 is peak pressure of the reﬂected wave. This index describes the relative
height of the reﬂected pressure wave when compared with the
incident waveform. Only recordings with a high signal quality were
accepted. Signal quality was assessed using the signal to noise (S/N) ratio
(in decibels), where S/N values 43 dB were considered acceptable.
Two measurements were taken, with 5-min interval. If AIx varied by 44%
or blood pressures by45 mm Hg, a third recording was made and the two
closest recordings were averaged.
Statistical analysis
Independent samples t-tests (age, certain lifestyle factors) and Pearson
Chi-squared tests (descent, family history of cardiovascular disease (CVD),
personal history of CVD, signs and symptoms of CVD, medication) were
used to compare baseline data between conditions (exercise, control).
A similar analysis was used to assess central and peripheral hemodynamic
properties (that is, cSBP, pSBP, peripheral diastolic blood pressure, central
pulse pressure, peripheral pulse pressure, AIx) at baseline, and to assess
medication use post-intervention. To assess the effect of the exercise
intervention on the aforementioned central and peripheral hemodynamic
properties, and following checks for normality to determine that these
outcome variables were parametric, a series of a-priori repeated-measures
analysis of covariance (Test [baseline, post intervention] by Condition
[exercise, control], with baseline inserted as a covariate) were conducted.
An intention-to-treat analysis was used on all repeated-measures statistical
procedures, whereby the last recorded data from a participant’s
subsequent assessment was carried forward and used in place of any
missing assessments thereafter. Partial eta squared (ηp
2) was used to
demonstrate the strength of the effect of exercise on the various outcome
measures with .0099, .0588 and .1379 representing a small, medium and





Whereby, SSEffect is the estimated variance for a given outcome measure,
and SSError is the error variance that is attributable to the effect. Alpha was
set at 0.05. Statistical analyses were performed using Statistical Package for
Social Sciences version 22 (SPSS, Inc., Chicago, IL, USA). All data are
reported as means (s.d.), unless otherwise speciﬁed.
RESULTS
Participant recruitment, adherence and recurrent TIA risk
There were no differences in subject characteristics, medication use
or CVD risk factors at baseline between groups (P40.05; Tables 1
and 2 and Supplementary Table). Baseline assessments were
undertaken 8±3 days post diagnosis. Mean medication use post-
intervention was approaching signiﬁcance (P=0.09) with
Table 1. Baseline demographics for both exercise and control groups
Exercise Control P-value
n % n %
Participants (n) 25 53 22 47
Age (y) 66± 12 68± 10 0.606
Gender (n)
Male 17 68 18 82 0.288
Female 8 32 4 18
Stroke classiﬁcation
Ischaemic stroke 8 32 8 36 0.759
TIA 17 68 14 64 0.759
Family history of CVD
Myocardial infarction 10 40 10 45 0.713
Stroke 14 56 10 45 0.481
Personal history of CVD
Hypertension 13 52 17 77 0.105
High cholesterol 12 48 15 68 0.220
Diabetes 4 16 8 36 0.134
Heart problems 9 36 8 36 0.938
Artery diseases 1 4 0 0 0.344
Personal history of other health conditions
Thyroid disease 1 4 1 5 0.951
Lung disease 0 0 1 5 0.301
Asthma 5 20 1 5 0.106
Cancer 6 24 1 5 0.090
Kidney disease 1 4 1 5 0.951
Signs & symptoms of CVD
Chest pain 13 52 10 45 0.565
Dyspnea 14 56 11 50 0.581
Heart palpitations 7 28 7 32 0.849
Skipped heart beats 8 32 8 36 0.834
Heart murmur 4 15 4 18 0.895
Intermittent leg-pain 10 40 11 50 0.581
Syncope 11 44 9 41 0.743
Fatigue 12 48 11 50 0.894
Snoring 12 48 12 53 0.764
Back pain 11 44 7 32 0.342
Lifestyle factors
Current Smoker 0 0 1 5 0.301
Duration smoking (y) 54
Previous Smoker 10 44 17 77 0.466
Quit duration (y) 21± 16 26± 15
Alcohol consumption 12 48 15 74 0.220
Current weight loss plan 4 8 2 5 0.457
Everyday activity: sedentary 8 32 11 56 0.122
Light 14 56 10 45
Moderate 3 12 1 5
Vigorous 0 0 0 0
Abbreviations: CVD, cardiovascular disease; TIA, transient ischaemic attack.
Note: heart problems refer to myocardial infarction, coronary artery
disease and congestive heart failure. P-values are included to demonstrate
no signiﬁcant differences between groups at baseline.
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participants in the exercise group typically taking less medication
compared to those in the control group (Mean difference (95% CI);
0.67 (−1.48 to 0.13); Table 2). Participants randomized to the exercise
program attended, on average, 96% of the available sessions. There
were no adverse events from participation in the exercise program.
Central and peripheral hemodynamic variables
Table 3 summarises the mean values for the central and peripheral
hemodynamic properties measured at baseline and post inter-
vention for both exercise and control conditions. There were no
statistical differences in any of the peripheral or central
hemodynamic variables reported at baseline between the exercise
and control group (all P40.05). Analysis of covariance demon-
strated a signiﬁcant interaction for cSBP, pSBP and AIx (all
Po0.05), with the exercise group presenting lower values than
the control group post intervention. A signiﬁcant interaction was
also observed for peripheral pulse pressure and central pulse
pressure (both Po0.05). An increase in pulse pressure was
observed for the control group between baseline and post
intervention, but a decrease was observed with the
exercise group.
DISCUSSION
This is the ﬁrst study to demonstrate that cSBP and AIx are
signiﬁcantly reduced in participants with minor stroke and
high-risk TIA following participation in an exercise intervention,
soon after diagnosis. In the present study, despite similarities in
baseline demographics, the 7% improvement in cSBP following
participation in a 12-week exercise program equated to a large
effect size (ηp
2 = 0.11). The signiﬁcance of this ﬁnding is further
enhanced when considering that there was a large reduction in
medication use for those participants randomized to the exercise
Table 2. Number and percentage of people taking medication at
baseline and PI for both conditions (exercise and control)
Exercise Control Baseline PI





n 21 18 17 17 0.329 0.830
% 84 72 77 77
Anti-thrombotica
n 21 17 21 20 0.174 0.050b
% 84 68 95 91
Angiotensin converting enzyme inhibitor
n 13 13 12 13 0.968 0.724
% 52 52 55 59
Diuretics
n 2 1 2 2 0.926 0.508
% 8 4 9 9
Calcium blockers
n 2 2 5 5 0.179 0.179
% 8 8 23 23
Beta blockers
n 4 4 5 5 0.608 0.608
% 16 16 23 23
Anticoagulants
n 1 1 2 2 0.345 0.345
% 4 4 9 9
Angiotensin receptor blocker
n 2 1 0 0 0.174 0.160
% 8 4 0 0
Other anti-hypertensives
n 2 2 2 2 0.926 0.926
% 8 8 9 9
Mean medication use
X 3.78 3.08 3.76 3.76 0.947 0.094
s.d. 1.04 1.53 1.00 1.04
Abbreviations: Con, control; Ex, exercise group; PI, post-intervention. Mean
(± s.d.) medication use is also reported. aNumber of patients taking two
anti-thrombotics were n= 18 (exercise, baseline), n= 19 (control, baseline),
n= 8 (exercise, PI), n= 14 (control, PI). bSigniﬁcant difference between
groups (Po0.05).
Table 3. Mean (± s.d.) values for peripheral and central hemodynamic
variables at baseline and PI for both conditions (exercise and control)
Exercise Control P ηp
2
Baseline PI Baseline PI
MAP (mm Hg)
X 96 90 98 96 0.160 0.05
s.d. 13 12 14 15
pDBP (mm Hg)
X 77 73 77 75 0.518 0.01
s.d. 10 10 9 11
pSBP (mm Hg)
X 134 125 140 138 0.046a 0.09
s.d. 21 19 27 28
cSBP (mm Hg)
X 127 118 133 132 0.027a 0.11
s.d. 19 17 26 28
pPP (mm Hg)
X 57 52 62 63 0.037a 0.10
s.d. 14 12 22 24
cPP (mm Hg)
X 49 43 53 55 0.011a 0.14
s.d. 13 10 21 23
pSBP-cSBP (mm Hg)
X 6.4 6.8 6.8 6.1 0.419 0.02
s.d. 4.9 3.7 4.8 4.4
AIx (%)
X 119 104 102 115 0.045a 0.09
s.d. 47 49 43 67
Heart rate (b.p.m.)
X 59 59 65 62 0.406 0.02
s.d. 9 12 16 14
DP
X 7591 7429 7795 8685 0.468 0.01
s.d. 2359 1985 3737 3111
Abbreviations: AIx, augmentation index; b.p.m., beats per minute;
cPP, central pulse pressure; cSBP, central systolic blood pressure; DP,
double product; MAP, mean arterial blood pressure; pDP, peripheral double
product; pDBP, peripheral diastolic blood pressure; PI, post-intervention;
pPP, peripheral pulse pressure; pSBP, peripheral systolic blood pressure.
aSigniﬁcant difference between groups (Po0.05).
Effect of exercise on central blood pressure
J Faulkner et al
4
Journal of Human Hypertension (2016), 1 – 6
group, and when considering that there were no changes in cSBP
for those individuals who received usual care.
Of the various CVD risk factors that are often assessed in
patients with minor stroke and TIA following engagement in
an exercise program, peripheral blood pressure responses have
received the greatest attention.3,18–21 However, it has been
suggested that peripheral blood pressures may not accurately
reﬂect the effects of peak arterial blood pressure on centrally
located organs,4 nor the stress and loading on the left ventricle
and coronary arteries.7,8 Accordingly, in the present study, the
signiﬁcant reduction in cSBP is of pragmatic importance for this
population group, as individuals diagnosed with stroke and TIA
are at a heightened risk of experiencing further cardiovascular
complications.5,6 It is interesting to note that the 9 mm Hg mean
reduction in cSBP is greater than that reported in a recent
meta-analysis, whereby, on average, a 4 mm Hg reduction in
peripheral blood pressure is suggested to occur following lifestyle
and behavioural interventions.3 The prescription of exercise at a
moderate- to high-intensity in the current study may be an
underpinning reason for this difference. Nevertheless, as the
reduction in pSBP was identical to that reported for cSBP for those
in the exercise group, the ecological beneﬁt of monitoring cSBP
may be somewhat reduced. In the current study, the exercise
group also demonstrated a signiﬁcant reduction in central and
peripheral pulse pressure in comparison to the control group
(ηp
2 = 0.10 to 0.14). Because the statistically similar diastolic blood
pressures reported between conditions (exercise and control) and
assessment sessions (baseline, post-intervention), the ~ 5 mm Hg
reduction in pulse pressure for the exercise group is largely
derived by the aforementioned changes in systolic blood pressure
(Table 3).
A further novelty of the present study relates to the change in
AIx; an indicator of arterial wave reﬂection.22 In this study,
participants who took part in the exercise program demonstrated
a 15% reduction in AIx (Table 3). This ﬁnding is of signiﬁcant
importance for those with stroke/TIA as AIx is an indicator of
systemic arterial stiffness23 and demonstrates the contribution
made by the reﬂected pressure wave to the ascending aortic
pressure waveform.22 Conversely, and unexpectedly, AIx increased
for the control group. Increased arterial wave reﬂections have
been reported to have adverse effects on ventricular afterload and
coronary perfusion, have been signiﬁcantly correlated to the
degree of coronary artery disease,24 and independently predict
cardiovascular risk and mortality.25 When considering that
stroke and TIA patients have an elevated risk of experiencing
cardiovascular and cerebrovascular events post stroke/TIA,1 the
measurement of central hemodynamic parameters, including
cSBP and AIx, could provide clinicians with important diagnostic
and prognostic information beyond that provided by traditional
peripheral blood pressure readings. From a pragmatic standpoint,
oscillometric devices, like that used in the current study, can
provide clinicians with a quick, non-invasive and valid assessment
of such hemodynamic parameters.25–28 Despite this study being
sufﬁciently powered, it is plausible that the observed differences
in AIx between the experimental and control groups may be
associated with the relatively small sample size and thus, future
research should assess such hemodynamic parameters in a larger
TIA/minor stroke population.
A recent study reported that the monitoring of central blood
pressure, compared with peripheral blood pressure, aided in the
management of hypertension and led to decreased medication
use without adverse effects of left ventricular mass.29 Therefore,
future research should assess whether the monitoring of central
hemodynamic variables in those with minor stroke or TIA may
lead to similar, positive clinical outcome changes, which may lead
to more targeted treatment strategies for these population
groups. However, it is important to recognize that in the current
study there are some important ﬁndings with regards to
medication use (Table 2). At the time of follow-up, participants
who engaged in the exercise program were shown to be taking
signiﬁcantly fewer anti-thrombotic medications, and there was a
trend for taking fewer medications overall, compared to those
randomized to the usual care control group. When considering
that medicinal management is primarily carried out to have an
impact on the cardiovascular system, this ﬁnding is pertinent, and
reﬂects the value of engaging patients in an exercise program
soon after diagnosis.
In conclusion, the present study has demonstrated that
participation in an exercise program soon after stroke/TIA
diagnosis may elicit signiﬁcant changes in cSBP and AIx. It
may be important for stroke clinicians to consider central
hemodynamic parameters at diagnosis and during follow-up
assessments as these parameters may provide important
information beyond that provided by traditional peripheral blood
pressure readings. As automated oscillometric devices can
provide a valid, quick and non-invasive assessment of central
hemodynamic parameters, clinicians could consider the use of
such measurements in providing more targeted treatment
strategies for those with TIA or minor stroke.
What is known about this topic ?
● Behavioural interventions (that is, exercise and education) have
been shown to improve physiological and psycho-social health in
patients with TIA and minor stroke.
● Previous research with this population group has often focused on
the effect of exercise on peripheral hemodynamic parameters (that
is, peripheral blood pressure).
● The measurement of central hemodynamic parameters, including
central systolic blood pressure (cSBP) and arterial wave reﬂection
(that is, augmentation index, AIx), hold the potential to provide
stroke clinicians with important diagnostic and prognostic informa-
tion beyond that of peripheral blood pressure readings.
What this study adds?
● Participation in an exercise program soon after stroke/TIA diagnosis
may elicit signiﬁcant improvements in cSBP and AIx.
● Stroke clinicians may want to consider central hemodynamic
parameters at diagnosis and during follow-up assessments as these
parameters may provide important information beyond that
provided by traditional peripheral blood pressure readings.
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